Patents by Inventor Geoffrey R. Heintzelman

Geoffrey R. Heintzelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7759356
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: July 20, 2010
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Patent number: 7754730
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: July 13, 2010
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Publication number: 20090054429
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: October 23, 2008
    Publication date: February 26, 2009
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Patent number: 7468373
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: December 23, 2008
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Patent number: 7345052
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: March 18, 2008
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Patent number: 6958328
    Abstract: This invention provides novel arylindenopyridines of the formula: , and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: October 25, 2005
    Assignee: Ortho-McNeil Pharmaceutical, Inc
    Inventors: Geoffrey R. Heintzelman, Kristin M. Averill, John H. Dodd
  • Patent number: 6903109
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing Adensine A2a receptors or reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: June 7, 2005
    Assignee: Ortho-Muniel Pharmaceutical, Inc.
    Inventors: Geoffrey R. Heintzelman, Kristin M. Averill, John H. Dodd, Keith T. Demarest, Yuting Tang, Paul F. Jackson
  • Publication number: 20040127510
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: 1
    Type: Application
    Filed: October 3, 2003
    Publication date: July 1, 2004
    Inventors: Geoffrey R. Heintzelman, James Lawrence Bullington, Kenneth C. Rupert
  • Publication number: 20040082578
    Abstract: This invention provides novel arylindenopyridines of the formula: 1
    Type: Application
    Filed: September 27, 2002
    Publication date: April 29, 2004
    Inventors: Geoffrey R. Heintzelman, Kristin M. Averill, John H. Dodd, Keith T. Demarest, Yuting Tang, Paul F. Jackson
  • Publication number: 20030212089
    Abstract: This invention provides novel arylindenopyridines of the formula: 1
    Type: Application
    Filed: April 16, 2002
    Publication date: November 13, 2003
    Inventors: Geoffrey R. Heintzelman, Kristin M. Averill, John H. Dodd